These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22163166)

  • 21. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system.
    Zhang Z; Cui C; Wei F; Lv H
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
    Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
    Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation
    Li F; Chen X; He Y; Peng Z
    ACS Appl Bio Mater; 2024 Mar; 7(3):1976-1989. PubMed ID: 38447202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles.
    Li Y; Bi Y; Xi Y; Li L
    J Drug Target; 2013 Feb; 21(2):188-99. PubMed ID: 23126604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model.
    Roerig J; Schiller L; Kalwa H; Hause G; Vissiennon C; Hacker MC; Wölk C; Schulz-Siegmund M
    Eur J Pharm Biopharm; 2021 Sep; 166():61-74. PubMed ID: 34077790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.
    Nie S; Hsiao WL; Pan W; Yang Z
    Int J Nanomedicine; 2011; 6():151-66. PubMed ID: 21499415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEG-coated vesicles from Pluronic/lipid mixtures for the carrying of photoactive erythrosine derivatives.
    de Freitas CF; Calori IR; da Silva ACP; de Castro LV; Sato F; Silva Pellosi D; Tessaro AL; Caetano W; Hioka N
    Colloids Surf B Biointerfaces; 2019 Mar; 175():530-544. PubMed ID: 30579054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
    Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
    Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
    Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
    J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases.
    De Leo V; Ruscigno S; Trapani A; Di Gioia S; Milano F; Mandracchia D; Comparelli R; Castellani S; Agostiano A; Trapani G; Catucci L; Conese M
    Int J Pharm; 2018 Jul; 545(1-2):378-388. PubMed ID: 29678545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.
    Chen Z; Deng J; Zhao Y; Tao T
    Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities.
    Mohamed EA; Abu Hashim II; Yusif RM; Suddek GM; Shaaban AAA; Badria FAE
    Eur J Pharm Sci; 2017 Jan; 96():232-242. PubMed ID: 27667706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
    Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
    Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery.
    Zariwala MG; Bendre H; Markiv A; Farnaud S; Renshaw D; Taylor KM; Somavarapu S
    Int J Nanomedicine; 2018; 13():5837-5848. PubMed ID: 30310283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
    Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
    Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.